News

Researchers from the University Hospital Zurich in Switzerland find that food seems to be a relevant trigger factor for abdominal angioedema attacks in patients with HAE.

Researchers from the Washington University School of Medicine have discovered an investigational therapy that could potentially benefit patients with an inherited form of ALS.

The development of new tools to quantify the many ways that rare diseases like FCS can affect patients is imperative.

Overweight and obesity in people with HIV are linked to behavioral factors and longer lives, not adverse effects of antiretroviral therapy, according to a new study.

In prior studies, younger populations that have asthma were not found to be impacted by autonomy preferences.

Investigators explore if polio can be used as a potential treatment for glioblastoma, an aggressive form of cancer that currently has no cure.

PAL-003 phase 2 extension study of long-term pegvaliase treatment in patients with phenylketonuria demonstrates substantial efficacy in maintaining reduced blood Phe concentration.

Yale Cancer Center scientists find that some rare hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair.

Researcher from the Indiana University School of Medicine found that at well-child visits 4.4% of fathers reported symptoms of depression compared to 5% of mothers.

If these results are confirmed by future research, the use of blood eosinophil count tests could improve patient care and reduce asthma-associated healthcare costs.

After 18 months of treatment, Study 201 participants at the highest treatment dose demonstrated a statistically significant slowing of cognitive decline of 30% compared to placebo.

Researchers map family trees of cancer cells in acute myeloid leukemia to better understand how the cancer responds to new drug, enasidenib.

Patients in the intensive blood pressure treatment group had a 19% lower risk of developing mild cognitive impairment compared to those given standard treatment, according to the SPRINT MIND study.

New research highlights the potential of fetal gene therapy to prevent and cure neonatal lethal neurodegenerative diseases in humans in utero.

The ECDC is currently investigating a multi-country outbreak of listeriosis linked to frozen vegetables that has been ongoing since 2015.

A new company says urine tests can help physicians determine whether a patient at risk of HIV infection is adhering to their pre-exposure prophylaxis regimen.

New guidelines on the prevention and treatment of HIV in adults from the IAS-USA Panel highlight advances made since the 2016 guidelines, as well as the need for new strategies.

At the 100-week mark, 89% of participants taking dolutegravir/rilpivirine (Juluca) maintained viral suppression, with viral loads of < 50 copies/mL.

Researchers say that adding a common altitude sickness drug to the treatment protocol for patients with glioblastoma may improve the effectiveness of chemotherapy and extend survival in some patients.

The first human clinical trial to assess RNA therapy, QR-313, for the treatment of recessive dystrophic epidermolysis bullosa has been initiated.

Elagolix (Orlissa) is the first oral gonadotropin-releasing hormone antagonist specifically developed for women with moderate to severe endometriosis pain.

A study of pediatric patients with asthma admitted to emergency departments has determined that while rhinovirus is the most prevalent infection, it is the non-rhinovirus pathogens that are associated with an increased absolute risk of treatment failure.

Researchers found that just 18.4% of young women diagnosed at pediatric emergency departments with pelvic inflammatory disease received HIV and syphilis screening, despite their higher risk for those sexually transmitted infections.

A workgroup convened by the Alzheimer’s Association has developed a list of 20 recommendations regarding symptoms of Alzheimer’s disease and related forms of dementia.

Researchers find that a glucose-derived dietary supplement was able to increase muscle-force production in a Duchenne muscular dystrophy mouse model by 50% in 10 days.

PharmaKrysto Ltd. and Rutgers University, New Jersey, have entered into a licensing agreement for the development of PK10, a novel drug for the treatment of cystinuria.

The PocketECG Cardiac Rehabilitation System provides electrocardiography (ECG) monitoring and alerts during cardiac rehabilitation.

Phase 2a clinical trial commences for repurposed drug, SOM3355, for the treatment of Huntington’s disease.

Researchers found that enhanced disinfection with UV light in targeted rooms led to a decrease in hospital-wide incidence of C. difficile and vancomycin-resistant enterococci.

A review of literature on depression and anxiety in patients with heart failure reports that 21.5% have depressive symptoms and 19% meet the criteria for a depressive disorder&mdash;2 to 3 times higher than rates in the general population.